Cover Image
市場調查報告書

中國的藥物輸送設備市場未來展望:中央靜脈導管,輸液系統,無針頭注射器,定量噴霧吸入器 (MDI)

China Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

出版商 GlobalData 商品編碼 537211
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
中國的藥物輸送設備市場未來展望:中央靜脈導管,輸液系統,無針頭注射器,定量噴霧吸入器 (MDI) China Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
出版日期: 2017年08月01日 內容資訊: 英文 120 Pages
簡介

本報告提供中國的各種的藥物輸送設備的市場相關分析,整體市場趨勢的轉變和預測 (過去·今後8年份),各產品類型詳細趨勢,主要企業·流通管道的市場佔有率,主要的開發中產品的目前臨床實驗情形,近來的資本交易·企業發展的動向,主要企業簡介等相關調查。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 藥物輸送設備市場明細
  • 本報告分析對象市場定義

第3章 中國的藥物輸送設備市場

  • 市場收益額趨勢:以金額為準 (總計15年份)
  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額:各類別佔有率比較 (總計15年份)
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模趨勢:以數量為準 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各企業

第4章 中國的中央靜脈導管市場

  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第5章 中國的輸液系統市場

  • 市場收益額結構:以金額為準
  • 市場收益額:各類別佔有率
  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
    • 可攜式輸液幫浦的市場收益額:實際成果值·預測值 (總計15年份)
    • 注射式幫浦的市場收益額:實際成果值·預測值 (總計15年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
    • 可攜式輸液幫浦的市場規模:實際成果值·預測值 (總計15年份)
    • 注射式幫浦的市場規模:實際成果值·預測值 (總計15年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第6章 中國的定量噴霧吸入器 (MDI) 市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第7章 中國的無針頭注射器市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第8章 主要企業簡介:中國的藥物輸送設備市場

  • Teleflex Inc
    • 企業概要
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Pfizer Inc
  • Baxter International Inc
  • B. Braun Melsungen AG
  • Merck & Co Inc
  • Smiths Medical
  • Terumo Corporation
  • Becton Dickinson and Co
  • Hospira Inc
  • Nipro
  • Medtronic plc

第9章 藥物輸送設備市場開發中產品

第10章 資本交易環境

  • 資產交易
  • 發行公司債券
  • 股票上市
  • 產業聯盟

第11章 近幾年主要的動向

  • 來自企業的發表 (企業·通訊)
  • 公佈財報
  • 產品新聞

第12章 附錄

圖表一覽

目錄
Product Code: GDMEMC0249DB

GlobalData's new report, "China Drug Delivery Devices Market Outlook to 2023", provides key market data on the China Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy:

  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Drug Delivery Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Drug Delivery Devices Market, China

  • 3.1. Drug Delivery Devices Market, China, Revenue ($m), 2009-2023
  • 3.2. Drug Delivery Devices Market, China, Revenue Mix ($m), 2016
  • 3.3. Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2016
  • 3.4. Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023
  • 3.5. Drug Delivery Devices Market, China, Revenue ($m), 2009-2016
  • 3.6. Drug Delivery Devices Market, China, Revenue ($m), 2016-2023
  • 3.7. Drug Delivery Devices Market, China, Volume (Units), 2009-2023
  • 3.8. Drug Delivery Devices Market, China, Volume (Units), 2009-2016
  • 3.9. Drug Delivery Devices Market, China, Volume (Units), 2016-2023
  • 3.10. Drug Delivery Devices Market, China, Company Share by Revenue ($m), 2016

4. Central Venous Catheters Market, China

  • 4.1. Central Venous Catheters Market, China, Revenue Mix ($m), 2016
  • 4.2. Central Venous Catheters Market, China, Segment Contribution (%), 2016
  • 4.3. Central Venous Catheters Market, China, Revenue ($m), 2009-2016
  • 4.4. Central Venous Catheters Market, China, Revenue ($m), 2016-2023
  • 4.5. Central Venous Catheters Market, China, Volume (Units), 2009-2016
  • 4.6. Central Venous Catheters Market, China, Volume (Units), 2016-2023
  • 4.7. Central Venous Catheters Market, China, Distribution Share by Revenue ($m), 2015-2016
  • 4.8. Central Venous Catheters Market, China, Company Share by Revenue ($m), 2016

5. Infusion Systems Market, China

  • 5.1. Infusion Systems Market, China, Revenue Mix ($m), 2016
  • 5.2. Infusion Systems Market, China, Segment Contribution (%), 2016
  • 5.3. Infusion Systems Market, China, Revenue ($m), 2009-2016
  • 5.4. Infusion Systems Market, China, Revenue ($m), 2016-2023
    • 5.4.1. Ambulatory Infusion Pumps Market, China, Revenue ($m), by Segment, 2009-2016
    • 5.4.2. Syringe Pumps Market, China, Revenue ($m), by Segment, 2009-2016
    • 5.4.3. Ambulatory Infusion Pumps Market, China, Revenue ($m), by Segment, 2016-2023
    • 5.4.4. Syringe Pumps Market, China, Revenue ($m), by Segment, 2016-2023
  • 5.5. Infusion Systems Market, China, Volume (Units), 2009-2016
  • 5.6. Infusion Systems Market, China, Volume (Units), 2016-2023
    • 5.6.1. Ambulatory Infusion Pumps Market, China, Volume (Units), by Segment, 2009-2016
    • 5.6.2. Syringe Pumps Market, China, Volume (Units), by Segment, 2009-2016
    • 5.6.3. Ambulatory Infusion Pumps Market, China, Volume (Units), by Segment, 2016-2023
    • 5.6.4. Syringe Pumps Market, China, Volume (Units), by Segment, 2016-2023
  • 5.7. Infusion Systems Market, China, Distribution Share by Revenue ($m), 2015-2016
  • 5.8. Infusion Systems Market, China, Company Share by Revenue ($m), 2016

6. Metered Dose Inhaler Devices Market, China

  • 6.1. Metered Dose Inhaler Devices Market, China, Revenue ($m), 2009-2016
  • 6.2. Metered Dose Inhaler Devices Market, China, Revenue ($m), 2016-2023
  • 6.3. Metered Dose Inhaler Devices Market, China, Volume (Units), 2009-2016
  • 6.4. Metered Dose Inhaler Devices Market, China, Volume (Units), 2016-2023
  • 6.5. Metered Dose Inhaler Devices Market, China, Distribution Share by Revenue ($m), 2015-2016
  • 6.6. Metered Dose Inhaler Devices Market, China, Company Share by Revenue ($m), 2016

7. Needle Free Injections Market, China

  • 7.1. Needle Free Injections Market, China, Revenue ($m), 2009-2016
  • 7.2. Needle Free Injections Market, China, Revenue ($m), 2016-2023
  • 7.3. Needle Free Injections Market, China, Volume (Units), 2009-2016
  • 7.4. Needle Free Injections Market, China, Volume (Units), 2016-2023
  • 7.5. Needle Free Injections Market, China, Distribution Share by Revenue ($m), 2015-2016
  • 7.6. Needle Free Injections Market, China, Company Share by Revenue ($m), 2016

8. Overview of Key Companies in China, Drug Delivery Devices Market

  • 8.1. Teleflex Inc
    • 8.1.1. Company Overview
  • 8.2. GlaxoSmithKline Plc
    • 8.2.1. Company Overview
  • 8.3. AstraZeneca Plc
    • 8.3.1. Company Overview
  • 8.4. Boehringer Ingelheim GmbH
    • 8.4.1. Company Overview
  • 8.5. Fresenius Kabi AG
    • 8.5.1. Company Overview
  • 8.6. Pfizer Inc
    • 8.6.1. Company Overview
  • 8.7. Baxter International Inc
    • 8.7.1. Company Overview
  • 8.8. B. Braun Melsungen AG
    • 8.8.1. Company Overview
  • 8.9. Merck & Co Inc
    • 8.9.1. Company Overview
  • 8.10. Smiths Medical
    • 8.10.1. Company Overview
  • 8.11. Terumo Corp
    • 8.11.1. Company Overview
  • 8.12. Becton Dickinson and Co
    • 8.12.1. Company Overview
  • 8.13. Hospira Inc
    • 8.13.1. Company Overview
  • 8.14. Nipro Corp
    • 8.14.1. Company Overview
  • 8.15. Medtronic plc
    • 8.15.1. Company Overview

9. Drug Delivery Devices Market Pipeline Products

10. Financial Deals Landscape

  • 10.1. Asset Transactions
    • 10.1.1. ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • 10.2. Debt Offerings
    • 10.2.1. Sichuan Kelun Pharma to Raise up to USD147.6 Million in Public Offering of Bonds Due 2020
    • 10.2.2. Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022
    • 10.2.3. Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds
    • 10.2.4. Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds
  • 10.3. Equity Offerings
    • 10.3.1. Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million
    • 10.3.2. Shandong Sito Bio-technology Raises USD155.6 Million in IPO of Shares
  • 10.4. Partnerships
    • 10.4.1. Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
    • 10.4.2. Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    • 10.4.3. Pfizer Terminates its Licensing Agreement with pSivida
    • 10.4.4. Bayer Enters into Licensing Agreement with DelSiTech
    • 10.4.5. BioCorRx Enters into Licensing Agreement with Therakine

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Dec 07, 2016: MicroPort EP Attends Dunhuang Cardiovascular Disease Forum
    • 11.1.2. Sep 01, 2016: First Firehawk Implantation in East Europe Completed
    • 11.1.3. Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China
  • 11.2. Financial Announcements
    • 11.2.1. Mar 30, 2017: MPSC Announces 2016 Annual Results
    • 11.2.2. Mar 24, 2017: LifeTech Announces 2016 Annual Results
    • 11.2.3. Aug 30, 2016: MPSC Announces 2016 Interim Results
  • 11.3. Product News
    • 11.3.1. May 25, 2017: APR Applied Pharma Research at the 9th ChinaBio Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
    • 12.1.6. Benchmarking
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2009-2023
  • Table 2: Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2016
  • Table 3: Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023
  • Table 4: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 5: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 6: Drug Delivery Devices Market, China, Volume (Units), 2009-2023
  • Table 7: Drug Delivery Devices Market, China, Volume (Units), Historic, 2009-2016
  • Table 8: Drug Delivery Devices Market, China, Volume (Units), Forecast, 2016-2023
  • Table 9: Drug Delivery Devices Market, China, Company Share by Revenue ($m), USD Constant, 2016
  • Table 10: Central Venous Catheters Market, China, Segment Contribution (%), 2016
  • Table 11: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 12: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 13: Central Venous Catheters Market, China, Volume (Units), Historic, 2009-2016
  • Table 14: Central Venous Catheters Market, China, Volume (Units), Forecast, 2016-2023
  • Table 15: Central Venous Catheters Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 16: Central Venous Catheters Market, China, Company Share by Revenue ($m), USD Constant, 2016
  • Table 17: Infusion Systems Market, China, Segment Contribution (%), 2016
  • Table 18: Infusion Systems Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 19: Infusion Systems Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 20: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 21: Syringe Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 22: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 23: Syringe Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 24: Infusion Systems Market, China, Volume (Units), Historic, 2009-2016
  • Table 25: Infusion Systems Market, China, Volume (Units), Forecast, 2016-2023
  • Table 26: Ambulatory Infusion Pumps Market, China, Volume (Units), Historic, 2009-2016
  • Table 27: Syringe Pumps Market, China, Volume (Units), Historic, 2009-2016
  • Table 28: Ambulatory Infusion Pumps Market, China, Volume (Units), Forecast, 2016-2023
  • Table 29: Syringe Pumps Market, China, Volume (Units), Forecast, 2016-2023
  • Table 30: Infusion Systems Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 31: Infusion Systems Market, China, Company Share by Revenue ($m), USD Constant, 2016
  • Table 32: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 33: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 34: Metered Dose Inhaler Devices Market, China, Volume (Units), Historic, 2009-2016
  • Table 35: Metered Dose Inhaler Devices Market, China, Volume (Units), Forecast, 2016-2023
  • Table 36: Metered Dose Inhaler Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 37: Metered Dose Inhaler Devices Market, China, Company Share by Revenue ($m), USD Constant, 2016
  • Table 38: Needle Free Injections Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 39: Needle Free Injections Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 40: Needle Free Injections Market, China, Volume (Units), Historic, 2009-2016
  • Table 41: Needle Free Injections Market, China, Volume (Units), Forecast, 2016-2023
  • Table 42: Needle Free Injections Market, China, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 43: Needle Free Injections Market, China, Company Share by Revenue ($m), USD Constant, 2016
  • Table 44: Drug Delivery Devices Market Pipeline Products
  • Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • Table 46: Sichuan Kelun Pharma to Raise up to USD147.6 Million in Public Offering of Bonds Due 2020
  • Table 47: Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022
  • Table 48: Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds
  • Table 49: Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds
  • Table 50: Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million
  • Table 51: Shandong Sito Bio-technology Raises USD155.6 Million in IPO of Shares
  • Table 52: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
  • Table 53: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
  • Table 54: Pfizer Terminates its Licensing Agreement with pSivida
  • Table 55: Bayer Enters into Licensing Agreement with DelSiTech
  • Table 56: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures

  • Figure 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2009-2023
  • Figure 2: Drug Delivery Devices Market, China, Revenue Mix ($m), 2016
  • Figure 3: Drug Delivery Devices Market, China, Category Contribution (%), 2016
  • Figure 4: Drug Delivery Devices Market, China, Category Comparison by Revenue ($m), 2009-2023
  • Figure 5: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 6: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 7: Drug Delivery Devices Market, China, Volume (Units), 2009-2023
  • Figure 8: Drug Delivery Devices Market, China, Volume (Units), Historic, 2009-2016
  • Figure 9: Drug Delivery Devices Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 10: Drug Delivery Devices Market, China, Company Share (%) 2016
  • Figure 11: Central Venous Catheters Market, China, Revenue Mix ($m), 2016
  • Figure 12: Central Venous Catheters Market, China, Segment Contribution (%), 2016
  • Figure 13: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 14: Central Venous Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 15: Central Venous Catheters Market, China, Volume (Units), Historic, 2009-2016
  • Figure 16: Central Venous Catheters Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 17: Central Venous Catheters Market, China, Company Share (%) 2016
  • Figure 18: Infusion Systems Market, China, Revenue Mix ($m), 2016
  • Figure 19: Infusion Systems Market, China, Segment Contribution (%), 2016
  • Figure 20: Infusion Systems Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 21: Infusion Systems Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 22: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 23: Syringe Pumps Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 24: Ambulatory Infusion Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 25: Syringe Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 26: Infusion Systems Market, China, Volume (Units), Historic, 2009-2016
  • Figure 27: Infusion Systems Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 28: Ambulatory Infusion Pumps Market, China, Volume (Units), Historic, 2009-2016
  • Figure 29: Syringe Pumps Market, China, Volume (Units), Historic, 2009-2016
  • Figure 30: Ambulatory Infusion Pumps Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 31: Syringe Pumps Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 32: Infusion Systems Market, China, Company Share (%) 2016
  • Figure 33: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 34: Metered Dose Inhaler Devices Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 35: Metered Dose Inhaler Devices Market, China, Volume (Units), Historic, 2009-2016
  • Figure 36: Metered Dose Inhaler Devices Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 37: Metered Dose Inhaler Devices Market, China, Company Share (%) 2016
  • Figure 38: Needle Free Injections Market, China, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 39: Needle Free Injections Market, China, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 40: Needle Free Injections Market, China, Volume (Units), Historic, 2009-2016
  • Figure 41: Needle Free Injections Market, China, Volume (Units), Forecast, 2016-2023
  • Figure 42: Needle Free Injections Market, China, Company Share (%) 2016
Back to Top